About Marker Therapeutics
Investors/Media
SEC Filings
    Filing date Form Description View
    8-K

    Report of unscheduled material events or corporate event

    EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
    PRE 14A

    A preliminary proxy statement providing notification matters to be brought to a vote

    View HTML
    4

    Statement of changes in beneficial ownership of securities

    View HTML
    4

    Statement of changes in beneficial ownership of securities

    View HTML
    4

    Statement of changes in beneficial ownership of securities

    View HTML
    8-K

    Report of unscheduled material events or corporate event

    EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
    424B5

    Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3

    View HTML
    10-K

    Annual report which provides a comprehensive overview of the company for the past year

    EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
    4

    Statement of changes in beneficial ownership of securities

    View HTML
    4

    Statement of changes in beneficial ownership of securities

    View HTML

    Data provided by Kaleidoscope.